Akoustis Receives an Additional Purchase Order for $13 Million XBAW®[...]
Quarterly Report for Quarter Ending JUNE 30, 2024 (Form 10-Q)
Artelo Biosciences Reports Second Quarter 2024 Financial Results and[...]
13/08/2024 | Press release | Distributed by Public on 13/08/2024 11:50
Please select the service you want to use:
Smartlinks | Entrada Therapeutics Inc. | News | Health | Company News | Securities Issuers | Biotechnology and Medical Research Companies | NYSE American | NYSE ARCA Equities | Nasdaq Global Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | FINRA Alternative Display Facility (ADF) | Nasdaq PSX | NYSE Chicago
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact